Skip to main content

Find Clinical Trials

Home
Conditions
Metabolic Syndrome X

Clinical trial condition

Metabolic Syndrome X

Explore clinical trials studying Metabolic Syndrome X. Study availability and eligibility vary by location and protocol.

151 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Metabolic Syndrome X trial results

Completed

An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics

NCT00448630

Conditions: Glucose Metabolism Disorders, Hyperinsulinism, Insulin Resistance, +7 more
Locations: Adana Psychiatry and Neurology Hospital Kurttepe, Adana, Turkey (Türkiye)

Pfizer Investigational Site Kurttepe, Adana, Turkey (Türkiye)

Adana Psychiatry and Neurology Hospital Adana, Turkey (Türkiye)

Cukurova University Scool of Medicine Adana, Turkey (Türkiye)

View all 47 locations

View Trial Details

Completed

Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)

NCT00455403

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +21 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Mechanisms of Cerebrovascular Control

NCT02936687

Conditions: Aneurysm, Cardiovascular Diseases, Glucose Metabolism Disorders, +7 more
Locations: University of Wisconsin, Madison Madison, Wisconsin, United States

View Trial Details

Completed

Exercise Training Effects on Metabolic Syndrome: Interactions With Medication

NCT03019796

Conditions: Cardiorespiratory Fitness, Exercise Therapy, Glucose Metabolism Disorders, +6 more
Locations: University of Castilla-La Mancha (Exercise Physiology Lab) Toledo, Spain

View Trial Details

Completed

Side Effects of Antipsychotic Medications

NCT00363181

Conditions: Body Weight, Body Weight Changes, Glucose Metabolism Disorders, +14 more
Locations: VA Palo Alto Health Care System Palo Alto, California, United States

View Trial Details

Completed

Berberine as Adjuvant Treatment for Schizophrenia Patients

NCT02983188

Conditions: Glucose Metabolism Disorders, Hyperinsulinism, Insulin Resistance, +7 more
Locations: Castle Peak Hospital - The Department of General Adult Psychiatry Tuenmen, Hong Kong

View Trial Details

Completed

Effect of Banaba (Lagerstroemia Speciosa) on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity

NCT02767869

Conditions: Body Weight, Glucose Metabolism Disorders, Hyperinsulinism, +12 more
Locations: Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Guadalajara, Jalisco, Mexico

View Trial Details

Completed

Physical Activity on Prescription in Patients With Metabolic Risk Factors.

NCT03012516

Conditions: Activities of Daily Living, Behavior, Glucose Metabolism Disorders, +9 more
Locations: Närhälsan FaR-teamet centrala och västra Göteborg Gothenburg, Region Västra Götaland, Sweden

View Trial Details

Completed

Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes

NCT00338949

Conditions: Glucose Metabolism Disorders, Hyperinsulinism, Insulin Resistance, +8 more
Locations: VA San Diego Healthcare System San Diego, California, United States

View Trial Details

Completed

Effect of Dapagliflozin Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion

NCT02113241

Conditions: Glucose Metabolism Disorders, Hyperinsulinism, Insulin Resistance, +4 more
Locations: Instituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara Guadalajara, Jalisco, Mexico

View Trial Details